DUBAI, United Arab Emirates, 01 Feb. 2022 (GLOBE NEWSWIRE) — The world Cotinine Testing Devices Market value of recorded sales US$429.9 million in 2021. The market is expected to expand at a cumulative CAGR of 4.7% and will grow 1.4X by the end of 2029, where sales are expected to be worth US$621.4 million.
According to a new market research report from Future Market Insights, the global cotinine testing devices market was valued at around US$429.9 million in 2021 and is expected to grow at a CAGR of around 4.7% during the forecast period 2022-2029. The report examines the Cotinine Testing Devices market and provides key insights for the forecast period 2022-2029.
According to the findings of the report, the global cotinine testing devices market is expected to witness significant growth over the forecast period, which will be triggered by a multitude of factors such as the increasing emphasis on “ value” and strong demand for effective screening techniques.
Request a sample report for complete information on https://www.futuremarketinsights.com/reports/sample/rep-gb-8472
| Data points | Market overview | |
| Market value 2022 | US$450.3 million | |
| Market value 2029 | US$621.4 million | |
| CAGR 2022-2029 | 4.7% | |
| Share of top 5 countries | 71.9% | |
| Key players | Major players in the Cotinine Testing Devices Market are Abbott Laboratories, AlcoPro, Jant Pharmacal Corporation, Sinocare Inc., Mossman Associates, Nano-Ditech Corp, LifeSign LLC, ALFA Scientific, Ameritek USA., Hangzhou Clongene Biotech Co. and Germaine Laboratories. , Inc. | |
Develop markets to reflect new growth opportunities
Regions such as North America and Europe are expected to hold a major market share in terms of value. However, developing markets are expected to anticipate lucrative growth in the Global Cotinine Testing Devices Market over the forecast period 2022-2029. The exponential increase in workplace testing is one of the key drivers that is opening up new growth avenues for manufacturers of cotinine testing devices that they can take advantage of. Economic and technological parity of developing regions with developed regions is another major factor estimated to generate stable sales revenue for Cotinine Testing Devices market players.
Additionally, the increasing level of awareness and adoption of useful products in smoking cessation programs further enhances the lucrativeness of developing markets such as China, India, and Brazil. Factors such as rising prevalence of smoking, employee illicit drug testing, sporting events, and health plan premium decision are expected to boost sales of cotinine testing devices in developing countries.
The burgeoning middle class population along with the multiple compliances created for recruitment into the armed forces are expected to increase the potential use cases of cotinine testing devices in 2022 and beyond. Contract manufacturing services available in developing markets, coupled with cheap labor, are expected to boost the investment quotient and attractiveness of developing countries, making them hotbeds of opportunity of growth.
For any questions related to the report, ask an analyst@ https://www.futuremarketinsights.com/ask-question/rep-gb-8472
Report scope
| Attributes | Details |
| Forecast period | 2022-2029 |
| Historical data available for | 2014-2021 |
| Market analysis | Million USD for value |
| Main countries covered | United States, Canada, Germany, United Kingdom, France, Italy, Spain, Russia, China, Japan, South Korea, India, Thailand, Malaysia, Indonesia, Australia, New Zealand, GCC Countries, Turkey, South Africa South. |
| Key Segments Covered | Device type, sample type, end user and region |
| Profiled Key Companies | • Abbott Laboratories • AlcoPro inc. • Jant Pharmaceutical Corporation • Sinocare Inc.,(PTS Diagnostics) • Mossman Associates • Nano-Ditech Corp. • LifeSign LLC • ALFA Scientific • Ameritek United States. • Hangzhou Clogene Biotech Co. • Germaine Laboratories, Inc. |
| Report cover | Market forecasts, competitive intelligence, DROT analysis, market dynamics and challenges, strategic growth initiatives |
End users should view marked preferences for cassettes
By device type, cassettes are expected to hold significant value shares of the global cotinine screening devices market. This is primarily a result of the cost effectiveness, ease of screening, rapid detection and portability of these compact cotinine screening devices. The report profiles the leading Cotinine Testing Devices market players whose success is driven by their strong portfolios and regional presence.
We offer bespoke solutions to meet your needs, request customization @ https://www.futuremarketinsights.com/customization-available/rep-gb-8472
The global cotinine testing devices market is significantly consolidated with a group of players holding major market shares. These players offer cotinine screening devices under their popular brands such as Accutest®, ALERE ISCREEN®, Reditest®, QuickProfile™, NicCheck™ I, DrugCheck® SalivaScan™, TobacAlert®, among others. Mergers and acquisitions will remain one of the key elements in the growth and expansion strategies of players in the cotinine testing devices market, with a focus on building new business models as well as distribution channels .
Discover IMF’s extensive ongoing healthcare coverage
Non-Invasive Blood Glucose Monitoring Devices Market – Diabetes has become one of the major healthcare epidemics characterized by high sugar levels and the leading cause of death worldwide. In 2014, the World Health Organization (WHO) estimated that 8.5% of adults were living with diabetes.
Remote Patient Monitoring Devices Market – Remote Patient Monitoring Devices supports patient physical status monitoring. The patient does not need to consult the doctor. Digital technology is used in remote patient monitoring devices to collect health data and other forms of medical data to be transmitted securely to healthcare providers at different locations for clinical review.
Point-of-Care Blood Testing Devices Market – The global point-of-care blood testing devices market is driven by the growing public awareness of diabetes in adults and children. The major market drivers are the increasing incidence of diabetes and different types of medical tests.
Radiation Therapy Positioning Devices Market – Radiation Therapy Positioning Devices are used to position patients during the radiation therapy session. Patient positioning and immobilization are important during radiation treatment.
Cataract Surgery Devices Market – Cataract surgery involves removing the cloudy natural lens from the eye and replacing it with an artificial lens that helps restore vision to the eye. Without surgically removing the cataract, most cataract patients suffered from blurred vision or even complete blindness.
Pathology Devices Market – Rising prevalence of chronic diseases, growing number of geriatric people, and active government initiatives to regulate infectious disease preventive measures have triggered the growth of the pathology devices market globally.
Intraosseous Devices Market – Intraosseous infusion is primarily used in pre-hospital pediatric emergencies where intravenous administration of fluids and medications is difficult. The increasing prevalence of various forms of diseases and the growing number of traumatic surgeries are expected to create a demand for these devices in the coming years.
Homecare Medical Devices Market – Homecare medical devices are intended for use in any environment outside of a professional healthcare facility. The user may be a patient, caregiver, or family member who directly uses the home care medical device or provides assistance in using the home care medical device.
X-Ray Positioning Devices Market – X-ray (abbreviated as X-ray) is a kind of electromagnetic radiation, ranging from 0.01 to 10 nm and corresponding to frequencies between 30 petahertz and 30 exahertz. They have been essential in the field of medical imaging since the discovery by Wilhelm Rontgen that they can be used to identify bone structure.
Electromyography Devices Market – Electromyography devices are powerful and flexible enough to be used for rehabilitation of injured muscles, relaxation training of tight muscles as well as training of muscles needed to improve incontinence.
About Future Market Insights (IMF)
Future Market Insights (FMI) is a leading provider of market information and advisory services, serving clients in over 150 countries. FMI is headquartered in Dubai and has delivery centers in the UK, USA and India. FMI’s latest market research reports and industry analysis help businesses meet challenges and make critical decisions with confidence and clarity amidst fierce competition. Our custom and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of analysts led by FMI experts continuously monitor emerging trends and events across a wide range of industries to ensure our clients are prepared for the changing needs of their consumers.
Contact:
future market outlook,
1602-6 Jumeirah Bay Tower X2,
Parcel number: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
For sales inquiries: sales@futuremarketinsights.com
For media inquiries: press@futuremarketinsights.com
Website: https://www.futuremarketinsights.com/
Report: https://www.futuremarketinsights.com/reports/cotinine-screening-devices-market
Source of press release: https://www.futuremarketinsights.com/press-release/cotinine-screening-devices-market
Comments are closed.